• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK INC COOK SPECTRUM; FOZ CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK INC COOK SPECTRUM; FOZ CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS Back to Search Results
Model Number N/A
Device Problem Material Separation (1562)
Patient Problems Foreign Body In Patient (2687); No Code Available (3191)
Event Date 07/21/2020
Event Type  Injury  
Manufacturer Narrative
Brand name: cook spectrum minocycline/rifampin impregnated five lumen central venous catheter set.Customer (person): phone: (b)(6).Reporter occupation: general manager.Report source, other: internal personnel.(b)(4).This report includes information known at this time.A follow up report will be submitted should additional relevant information become available.
 
Event Description
It was reported that the wire of a cook spectrum minocycline/rifampin impregnated five lumen central venous catheter set separated upon removal from the patient.The physician used the seldinger technique through the subclavian vein to introduce the wire with no issues.There was no difficulty gaining access to the intended vessel or dilating the tissue, and the vessel was accessed on the first attempt.During vessel access, the wire was not repositioned.The wire was not manipulated through a needle.The device was placed in the subclavian without any supporting imaging to assist.Upon removal of the wire, it was found to be broken.The wire could not be removed fully as it was stuck in the patient's muscular tissue and inside the vessel.The patient was taken to the emergency room for an additional surgery to remove the wire.The subcutaneous tissue was explored and the separated piece of wire was removed without complications.No other adverse effects have been reported.
 
Event Description
No additional information regarding patient/event details has been received since the previous medwatch report was sent.
 
Manufacturer Narrative
Additional information: section c.Investigation ¿ evaluation: it was reported that a wire guide from a cook spectrum minocycline/rifampin impregnated five lumen central venous catheter set (c-uqlm-1001j-rsc-abrm-hc-rd) from lot 10301064 broke.A fragment separated and became embedded in subcutaneous tissue, requiring surgery to remove.Cook became aware of this event on (b)(6) 2020 upon being notified by from (b)(6).The patient reportedly experienced no additional adverse effects as a result of this incident.Reviews of the complaint history, device history record (dhr), instructions for use (ifu), and quality control of the device were conducted during the investigation.The complaint device was not returned for evaluation.A document based investigation evaluation was performed.A review of the device master record found that proper procedures are in place to identify and prevent this failure mode prior to device distribution.A review of the design history file shows evidence of validations in place to meet design requirements related to this failure mode.A review of the device history record found one related nonconformance for the wire guide subassembly lot in which one device was scrapped due to a broken solder.A database search found one additional complaint from this device lot, reported by the same user facility for the same failure mode.There is no evidence to suggest there is any nonconforming product in house or out in the field.Additionally, a review of the product labeling for the device was completed.The instructions for use state the following instructions related to the reported failure mode: "precautions standard seldinger technique for placement for placement of percutaneous vascular access sheaths, catheters and wire guides should be employed during the placement of a central venous catheter.Instructions for use 4.If resistance is encountered during wire guide insertion, do not force wire guide.Withdrawal of wire guide through needle should be avoided; breakage may result.How supplied: upon removal from package, inspect the product to ensure no damage has occurred." based on the information provided, no product returned, and the results of the investigation, a definitive cause for separation was established as component failure unrelated to a manufacturing or design deficiency.Historical analysis of previous complaints has shown that withdrawal of the wire through the needle typically leads to wire guide damage.However, the customer reported not performing this action so this cause is not suspected.Forceful manipulation of the wire guide and/or tortuous patient anatomy may have contributed to the damage, but these cannot be confirmed without additional information.The appropriate personnel have been notified.Per the quality engineering risk assessment, no further action is required.Cook will continue to monitor for similar complaints.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COOK SPECTRUM
Type of Device
FOZ CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS
Manufacturer (Section D)
COOK INC
750 daniels way
bloomington IN 47404
MDR Report Key10368886
MDR Text Key203500912
Report Number1820334-2020-01435
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier00827002515390
UDI-Public(01)00827002515390(17)221120(10)10301064
Combination Product (y/n)Y
PMA/PMN Number
K081113
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Type of Report Initial,Followup
Report Date 10/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/05/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/20/2022
Device Model NumberN/A
Device Catalogue NumberC-UQLM-1001J-RSC-ABRM-HC-RD
Device Lot Number10301064
Was Device Available for Evaluation? No
Date Manufacturer Received10/07/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age63 YR
Patient Weight86
-
-